• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑脊液生物胺分析在原发性神经递质紊乱诊断中的应用。

Cerebrospinal Fluid Biogenic Monoamine Analysis for Diagnosis of Primary Neurotransmitter Disorders.

机构信息

Biochemistry Section, Department of Laboratory Medicine, P.D. Hinduja Hospital & Medical Research Center, Veer Savarkar Marg, Mahim, Mumbai, Maharashtra, 400016, India.

Department of Chemistry, Satish Pradhan Dnyanasadhana College, Thane, Maharashtra, India.

出版信息

Indian J Pediatr. 2021 Dec;88(12):1241-1243. doi: 10.1007/s12098-021-03956-6. Epub 2021 Sep 20.

DOI:10.1007/s12098-021-03956-6
PMID:34541626
Abstract

Biogenic amine neurotransmitters metabolism is a multistep pathway with pterin and pyridoxal phosphate (vitamin B6) as cofactors. A defect in biogenic amine and cofactor metabolism and vesicular transporters result in a primary neurotransmitter disorders. These are a well-recognized groups of inherited disorders and often present with features overlapping with other neurological conditions. Their diagnosis is made by analysis of biogenic amine metabolites in cerebrospinal fluid (CSF) and other body fluids and respective enzyme assays. Many of these disorders are treatable and deficits can be reverted by timely intervention. CSF biogenic amine or cofactor metabolite analysis is one of the primary indicators of a neurotransmitter disorder. In this paper, 3 cases are reported-2 of cofactor deficiency and 1 with enzyme deficiency wherein biogenic amine estimation has assisted in diagnosis.

摘要

生物胺神经递质代谢是一个多步骤的途径,蝶呤和吡哆醛磷酸(维生素 B6)作为辅助因子。生物胺和辅助因子代谢以及囊泡转运体的缺陷导致原发性神经递质紊乱。这些是一组公认的遗传性疾病,常与其他神经疾病的特征重叠。它们的诊断是通过分析脑脊液(CSF)和其他体液中的生物胺代谢物以及相应的酶分析来确定的。许多这些疾病是可治疗的,并且可以通过及时干预来逆转缺陷。CSF 生物胺或辅助因子代谢物分析是神经递质紊乱的主要指标之一。本文报告了 3 例病例 - 2 例为辅助因子缺乏症,1 例为酶缺乏症,其中生物胺测定有助于诊断。

相似文献

1
Cerebrospinal Fluid Biogenic Monoamine Analysis for Diagnosis of Primary Neurotransmitter Disorders.脑脊液生物胺分析在原发性神经递质紊乱诊断中的应用。
Indian J Pediatr. 2021 Dec;88(12):1241-1243. doi: 10.1007/s12098-021-03956-6. Epub 2021 Sep 20.
2
Approaches for diagnosis and treatment in neurotransmitter disorders of childhood.儿童神经递质障碍的诊断和治疗方法。
Metab Brain Dis. 2021 Dec;36(8):2255-2262. doi: 10.1007/s11011-021-00838-w. Epub 2021 Sep 22.
3
Clinical Use of CSF Neurotransmitters.脑脊液神经递质的临床应用
Pediatr Neurol. 2015 Oct;53(4):277-86. doi: 10.1016/j.pediatrneurol.2015.04.016. Epub 2015 Jun 11.
4
Cerebrospinal Fluid Concentrations of Neurotransmitters in a Greek Pediatric Reference Population.希腊儿科参考人群中的神经递质的脑脊液浓度。
Neuropediatrics. 2023 Apr;54(2):126-133. doi: 10.1055/a-1988-2412. Epub 2022 Nov 28.
5
Analysis of Catecholamines and Pterins in Inborn Errors of Monoamine Neurotransmitter Metabolism-From Past to Future.浅析单胺类神经递质代谢先天性缺陷中的儿茶酚胺和喋呤-从过去到未来。
Cells. 2019 Aug 9;8(8):867. doi: 10.3390/cells8080867.
6
Detection of 3-O-methyldopa in dried blood spots for neonatal diagnosis of aromatic L-amino-acid decarboxylase deficiency: The northeastern Italian experience.检测干血斑中的 3-O-甲基多巴用于新生儿诊断芳香族 L-氨基酸脱羧酶缺乏症:意大利东北部的经验。
Mol Genet Metab. 2021 May;133(1):56-62. doi: 10.1016/j.ymgme.2021.03.009. Epub 2021 Mar 13.
7
What is new for monoamine neurotransmitter disorders?单胺神经递质紊乱有哪些新进展?
J Inherit Metab Dis. 2014 Jul;37(4):619-26. doi: 10.1007/s10545-014-9697-4. Epub 2014 Apr 3.
8
Biogenic amine synthesis defect in dihydropteridine reductase deficiency.二氢蝶啶还原酶缺乏症中的生物胺合成缺陷。
Science. 1977 Nov 4;198(4316):522-3. doi: 10.1126/science.20665.
9
Blood, urine and cerebrospinal fluid analysis in TH and AADC deficiency and the effect of treatment.酪氨酸羟化酶和芳香族氨基酸脱羧酶缺乏症的血液、尿液和脑脊液分析及治疗效果
Mol Genet Metab Rep. 2021 Apr 26;27:100762. doi: 10.1016/j.ymgmr.2021.100762. eCollection 2021 Jun.
10
Aromatic amino acid decarboxylase deficiency: Molecular and metabolic basis and therapeutic outlook.芳香族氨基酸脱羧酶缺乏症:分子和代谢基础与治疗前景。
Mol Genet Metab. 2019 May;127(1):12-22. doi: 10.1016/j.ymgme.2019.03.009. Epub 2019 Mar 27.

本文引用的文献

1
Genetics of monoamine neurotransmitter disorders.单胺神经递质紊乱的遗传学。
Transl Pediatr. 2015 Apr;4(2):175-80. doi: 10.3978/j.issn.2224-4336.2015.03.01.